Amy Schulman - Dec 22, 2021 Form 4 Insider Report for SQZ Biotechnologies Co (SQZB)

Role
Director, 10%+ Owner
Signature
/s/ Lawrence Knopf, Attorney-in-Fact for Amy W. Schulman
Stock symbol
SQZB
Transactions as of
Dec 22, 2021
Transactions value $
$84,823
Form type
4
Date filed
12/23/2021, 04:15 PM
Previous filing
Dec 15, 2021
Next filing
Feb 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SQZB Common Stock Options Exercise $20.4K +10.1K +5.29% $2.02* 201K Dec 22, 2021 Direct F1
transaction SQZB Common Stock Options Exercise $34.2K +7.46K +3.71% $4.59* 208K Dec 22, 2021 Direct F1
transaction SQZB Common Stock Options Exercise $30.2K +6.58K +3.16% $4.59* 215K Dec 22, 2021 Direct F1
holding SQZB Common Stock 276K Dec 22, 2021 See footnote F2
holding SQZB Common Stock 178K Dec 22, 2021 See footnotes F3, F4
holding SQZB Common Stock 2.55M Dec 22, 2021 See footnotes F4, F5
holding SQZB Common Stock 1.85K Dec 22, 2021 See footnote F6
holding SQZB Common Stock 1.85K Dec 22, 2021 See footnote F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SQZB Stock Option Options Exercise $0 -10.1K -95.83% $0.00 439 Dec 22, 2021 Common Stock 10.1K $2.02 Direct F1, F8
transaction SQZB Stock Option Options Exercise $0 -7.46K -70.83% $0.00 3.07K Dec 22, 2021 Common Stock 7.46K $4.59 Direct F1, F9
transaction SQZB Stock Option Options Exercise $0 -6.58K -62.5% $0.00 3.95K Dec 22, 2021 Common Stock 6.58K $4.59 Direct F1, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options were exercised and held for tax planning purposes.
F2 These shares are held of record by LS Polaris Innovation Fund, L.P. ("LSPIF"). LS Polaris Innovation Fund GP, L.L.C. ("LSPIF GP") is the general partner of LSPIF. The Reporting Person is the sole managing member of LSPIF GP. Each of LSPIF GP and the Reporting Person may be deemed to have sole investment, voting and dispositive power over these shares. LSPIF GP and the Reporting Person disclaim beneficial ownership of the shares held by LSPIF and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
F3 These shares are held of record by Polaris Entrepreneurs' Fund VII, L.P. ("EF VII"). Polaris Management Co. VII, L.L.C. ("PMC VII") is the general partner of EF VII. David Barrett, Brian Chee, Amir Nashat and Bryce Youngren (the "Managing Members") are the managing members of PMC VII. The Reporting Person, a member of the Issuer's board of directors, holds an interest in PMC VII.
F4 Each of the Managing Members and the Reporting Person, in their respective capacities with respect to PMC VII, may be deemed to have shared investment, voting and dispositive power over these shares. Each of PMC VII, the Managing Members and the Reporting Person disclaim beneficial ownership of these shares and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
F5 These shares are held of record by Polaris Partners VII, L.P. ("PP VII"). PMC VII is the general partner of PP VII. The Managing Members are the managing members of PMC VII. The Reporting Person, a member of the Issuer's board of directors, holds an interest in PMC VII.
F6 These shares are held in trust 1 for the benefit of a child of the reporting person. The reporting person's spouse has investment authorization over the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F7 These shares are held in trust 2 for the benefit of a child of the reporting person. The reporting person's spouse has investment authorization over the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F8 The option vests and becomes exercisable as to 25% of the underlying securities on January 23, 2019 and in 36 equal monthly installments thereafter.
F9 The option vests and becomes exercisable as to 25% of the underlying securities on February 1, 2020 and in 36 equal monthly installments thereafter.
F10 The option vests and becomes exercisable in 48 equal monthly installments commencing on July 5, 2019.